360 High-Risk Vulnerability Immunization Tool V2.0 vs Armis Centrix™ for VIPR: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Armis Centrix™ for VIPR: Healthcare-focused vuln mgmt platform for medical device security & risk prioritization. built by Armis. Core capabilities include Real-time medical device inventory and visibility, Vulnerability detection and deduplication, Clinical Impact Score for patient safety prioritization..

Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Armis Centrix™ for VIPR differentiates with Real-time medical device inventory and visibility, Vulnerability detection and deduplication, Clinical Impact Score for patient safety prioritization.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Armis Centrix™ for VIPR is developed by Armis. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Armis Centrix™ for VIPR serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.